Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             44 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis Kinoshita, Yoshiaki
 2018
 125 C p. 198-204
 artikel
2 A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease Hanibuchi, Masaki
 2018
 125 C p. 93-99
 artikel
3 Applicability of the lung-molGPA index in non-small cell lung cancer patients with different gene alterations and brain metastases Chen, Kaiyan
 2018
 125 C p. 8-13
 artikel
4 Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer Cho, Jun Yeun
 2018
 125 C p. 150-156
 artikel
5 Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer Sotiropoulos, George P.
 2018
 125 C p. 291-299
 artikel
6 Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer Liu, Si-yang
 2018
 125 C p. 86-92
 artikel
7 Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer Lin, Mong-Wei
 2018
 125 C p. 282-290
 artikel
8 Comparative study of programmed cell death ligand-1 immunohistochemistry assays using 22C3 and 28-8 antibodies for non-small cell lung cancer: Analysis of 420 surgical specimens from Japanese patients Saito, Tomohito
 2018
 125 C p. 230-237
 artikel
9 Contents 2018
 125 C p. v-vii
 artikel
10 Corrigendum to “Routine preoperative brain CT in resectable non-small cell lung cancer—Ten years experience from a tertiary UK thoracic center” [Lung Cancer 122 (August) (2018) 195–199] Matys, Tomasz
 2018
 125 C p. 300
 artikel
11 CT-based radiomics signature for differentiating solitary granulomatous nodules from solid lung adenocarcinoma Yang, Xinguan
 2018
 125 C p. 109-114
 artikel
12 Detection of abundant megakaryocytes in pulmonary artery blood in lung cancer patients using a microfluidic platform Dejima, Hitoshi
 2018
 125 C p. 128-135
 artikel
13 Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer Djureinovic, Dijana
 2018
 125 C p. 157-163
 artikel
14 Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma Wei, Yu-Feng
 2018
 125 C p. 35-42
 artikel
15 Economic analysis of osimertinib in previously untreated EGFR-mutant advanced non-small cell lung cancer in Canada Ezeife, Doreen A.
 2018
 125 C p. 1-7
 artikel
16 Editorial Board 2018
 125 C p. iii
 artikel
17 EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP) Cardona, Andrés F.
 2018
 125 C p. 265-272
 artikel
18 Examining the role of access to care: Racial/ethnic differences in receipt of resection for early-stage non-small cell lung cancer among integrated system members and non-members Check, Devon K.
 2018
 125 C p. 51-56
 artikel
19 Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer Jia, Yijun
 2018
 125 C p. 22-28
 artikel
20 Increased incidence, morbidity and mortality rates for lung cancer in women in Brazil between 2000 and 2014: An analysis of three types of sources of secondary data Costa, Guilherme Jorge
 2018
 125 C p. 77-85
 artikel
21 LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease Karlsson, Terese
 2018
 125 C p. 174-184
 artikel
22 Local ablative treatment for synchronous single organ oligometastatic lung cancer—A propensity score analysis of 180 patients Frost, Nikolaj
 2018
 125 C p. 164-173
 artikel
23 Lung cancer mortality in Australia: Projected outcomes to 2040 Luo, Qingwei
 2018
 125 C p. 68-76
 artikel
24 Lung cancer screening – gaining consensus on next steps – proceedings of a closed workshop in the UK Moffat, J.
 2018
 125 C p. 121-127
 artikel
25 MET amplification increases the metastatic spread of EGFR-mutated NSCLC Baldacci, Simon
 2018
 125 C p. 57-67
 artikel
26 Minute ventilation-to-carbon dioxide slope is associated with postoperative survival after anatomical lung resection Miyazaki, Takuro
 2018
 125 C p. 218-222
 artikel
27 Multi-centre prospective study on diagnosing subtypes of lung cancer by exhaled-breath analysis Kort, S.
 2018
 125 C p. 223-229
 artikel
28 New risk scoring system for predicting acute exacerbation of interstitial pneumonia after chemotherapy for lung cancer associated with interstitial pneumonia Isobe, Kazutoshi
 2018
 125 C p. 253-257
 artikel
29 Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study Gadgeel, Shirish M.
 2018
 125 C p. 273-281
 artikel
30 Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non–small cell lung cancer Kawano, Yuko
 2018
 125 C p. 136-141
 artikel
31 Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH score Balata, Haval
 2018
 125 C p. 29-34
 artikel
32 Predictive accuracy of lepidic growth subtypes in early-stage adenocarcinoma of the lung by quantitative CT histogram and FDG-PET Eriguchi, Daisuke
 2018
 125 C p. 14-21
 artikel
33 Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis Yamaguchi, Teppei
 2018
 125 C p. 212-217
 artikel
34 Primary tracheal hyalinizing clear cell carcinoma Icard, Bradley
 2018
 125 C p. 100-102
 artikel
35 Prognostic impact of preoperative comorbidities in geriatric patients with early-stage lung cancer: Significance of sublobar resection as a compromise procedure Yutaka, Yojiro
 2018
 125 C p. 192-197
 artikel
36 Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer Wang, Shuyuan
 2018
 125 C p. 245-252
 artikel
37 Prospective study revealed prognostic significance of responses in leptomeningeal metastasis and clinical value of cerebrospinal fluid-based liquid biopsy Xu, Yan
 2018
 125 C p. 142-149
 artikel
38 Real-life treatment practice for malignant pleural mesothelioma in Belgium Rosskamp, Michael
 2018
 125 C p. 258-264
 artikel
39 Receipt of recommended surveillance with imaging in elderly survivors of early stage non-small cell lung cancer Malhotra, Jyoti
 2018
 125 C p. 205-211
 artikel
40 Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study Walter, Joan E.
 2018
 125 C p. 103-108
 artikel
41 Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC Ackerson, Bradley G.
 2018
 125 C p. 185-191
 artikel
42 The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression Ren, Shengxiang
 2018
 125 C p. 115-120
 artikel
43 Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis Wei, Yuqing
 2018
 125 C p. 43-50
 artikel
44 Use of health insurance data to identify and quantify the prevalence of main comorbidities in lung cancer patients Jegou, David
 2018
 125 C p. 238-244
 artikel
                             44 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland